About this trial
The aim of this study is to analyze the effects of isometric handgrip training (IHT) on blood pressure of hypertensive patients with peripheral arterial disease. Will be recruited 30 patients which will be randomized into 2 groups (15 per group), IHT and control group (CG). IHT group will training isometric contraction for 12 weeks. In CG patients will be encouraged to increase the level of physical activity. In the pre and post-intervention cardiovascular measures will be obtained.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women in post-menopause phase without hormone replacement therapy
Ankle-brachial index <0.90
Not severe obese (≥ 35kg/m2)
Not present amputation in the limbs
Disqualifiers
patients will only be excluded if they make any medication changes before completing the intervention period or present any health problems that prevent physical activity.
Trial design
Parallel
Treatments tested in this trial
Isometric handgrip training
Other interventionIntervention period will last 12 weeks. Experimental group will perform three sessions per week of home-based handgrip exercise. The exercise protocol will consist of eight sets of bilateral handgrip contraction of two minutes of isometric contraction, with 30% of maximum voluntary contraction, and two minutes of interval between sets. Patients will receive a diary to record the sessions and report difficulties during the training. The patients be recommended to increase daily physical activity levels, and weekly, there will be phone contacts with the patients to reinforce the exercise recommendations.
Control Group
Other interventionIntervention period will last 12 weeks. Patients will be recommended to increase daily physical activity levels, and weekly, there will be phone contacts to reinforce the recommendations.
Treatment groups
Trial outcomes
Primary outcomes
Change from baseline in blood pressure at 12 weeks
Blood pressure will be measured before and after 12 weeks of intervention period on intervention and control group by an automatic blood pressure monitor (HEM-742, Omron Healthcare, Japan).
Secondary outcomes
Change from baseline in cardiac autonomic modulation at 12 weeks
Cardiac autonomic modulation will be measured before and after 12 weeks of intervention period on intervention and control group by heart rate monitor (Polar, RS 800, USA).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Nove de Julho
Lead sponsor
Hospital Israelita Albert Einstein
Collaborator